Skip to main content
Isomer
  1. Home
  2. Automated
  3. List of product information
  4. CLIMADAN CAPSULE 150 MG [SIN11414P]

CLIMADAN CAPSULE 150 MG [SIN11414P]

Active ingredients: CLIMADAN CAPSULE 150 MG

Last updated 26 October 2025

Product Info

CLIMADAN CAPSULE 150 MG

[SIN11414P]

Product information

Active Ingredient and Strength

CLINDAMYCIN HCL - 150 MG

Dosage Form

CAPSULE

Manufacturer and Country

PT. DANKOS FARMA - INDONESIA REP OF

Registration Number

SIN11414P

Licence Holder

ZYFAS PHARMA PTE LTD

Forensic Classification

PRESCRIPTION ONLY MEDICINES

Anatomical Therapeutic Chemical (ATC) code

J01FF01

Indications :
Serious infections caused by organisms sensitive to CLIMADAN include upper and lower respiratory tract infections, otitis media, skin infections, osteomyelitis, endocarditis, anaerobic infections and others.
It is also indicated for prophylaxis of postoperative infections caused by anaerobic bacteria.

Dosage and administration :
Adults:
For Serious Infections: 150 mg – 300 mg / 6-hourly.
For More Severe Infections: 450 mg / 6-hourly.
Children > 1 month :
For Serious Infections : 8 – 16 mg/kg body weight/day given in 3 – 4 divided doses.
For More Severe Infections : 16 – 20 mg/kg body weight/day given in 3 – 4 divided doses.

Contraindications :
Patients hypersensitive to lincomycin and clindamycin.
Patients with diarrhoea, liver and kidney functions disturbances.
Atopic individuals, e.g. the asthmatic and allergic patients.
It is not indicated for meningitis and in the treatment of mild infections caused by bacteria and viruses.